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ABSTRAK 
 
PENGENALAN 
Penyakit jantung rheumatik atau rheumatik karditis adalah antara penyakit jantung yang 
paling kerap dihidapi oleh kanak-kanak di seluruh dunia dan masih kekal menjadi 
antara masalah kesihatan yang utama di negara-negara membangun. Setakat ini, tiada 
data tempatan mengenai penyakit jantung rheumatik klinikal dan penyakit jantung 
rheumatik subklinikal. 
 
OBJEKTIF: 
Objektif utama kajian ini adalah untuk menentukan jumlah pesakit yang mengalami 
penyakit jantung rheumatik klinikal dan subklinikal serta mengkaji faktor-faktor yang 
berkaitan dengan penyakit jantung rheumatik klinikal dan penyakit jantung rheumatik 
subklinikal di kalangan kanak-kanak yang dirawat di Hospital Universiti Sains 
Malaysia. 
 
KAEDAH : 
Kajian ini dijalankan melalui kajian rekod retrospektif pesakit jantung rheumatik yang 
dirujuk atau dimasukkan ke Hospital Universiti Sains Malaysia dari tahun 2002 hingga 
2014 yang memenuhi kriteria kajian. 
 
KEPUTUSAN: 
Terdapat 171 kes pesakit yang menghidap penyakit jantung rheumatik yang baru 
didiagnosa telah dimasukkan ke dalam kajian ini. Prevalens penyakit jantung rheumatik 
klinikal dan subklinikal adalah 86.5% dan 13.5% masing-masing. Purata umur sewaktu 
xiii 
 
diagnosa penyakit jantung rheumatik adalah 10.8 tahun dengan lelaki lebih ramai dari 
perempuan dengan kadar 1.1 kepada 1. Purata umur untuk penyakit jantung rheumatik 
subklinikal adalah 9 tahun dengan kebanyakannya perempuan. Semua pesakit yang 
menghidap penyakit jantung rheumatik yang terlibat dalam kajian ini berbangsa 
Melayu. Majoriti pesakit yang menghidap penyakit jantung rheumatik berasal dari 
kawasan luar bandar yang menyumbang sebanyak 60.2%. Pesakit dengan penyakit 
jantung rheumatik lebih ramai mempunyai adik-beradik yang lebih daripada 5 iaitu 
52.6% berbanding dengan bilangan adik-beradik yang kurang atau sama dengan 5 iaitu 
sebanyak 47.4%. Pendapatan isi rumah yang rendah mempunyai prevalens yang tinggi 
bagi penyakit jantung rheumatik klinikal, iaitu 78.7% kes berbanding dengan 56.3% kes 
bagi penyakit subklinikal. Kebanyakan ibubapa berpendidikan sehingga ke peringkat 
pendidikan sekolah menengah iaitu sebanyak 76.4%. Secara statistik, didapati hanya 
faktor umur pesakit yang mempunyai kaitan yang signifikan dengan penyakit jantung 
rheumatik subklinikal berbanding penyakit jantung rheumatik klinikal. 
 
KESIMPULAN 
Prevalens penyakit jantung rheumatik subklinikal dalam kajian ini setara berbanding 
kajian-kajian lain. Peningkatan usia pesakit boleh menyebabkan kurang kemungkinan 
untuk mendapat penyakit jantung rheumatik subklinikal berbanding penyakit jantung 
rheumatik klinikal. 
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ABSTRACT 
 
INTRODUCTION 
Rheumatic heart disease or rheumatic carditis remains the leading cause of acquired 
heart disease in children worldwide and continues to be an important public health 
problem in developing countries. To date, there is no local data regarding the clinical 
and subclinical rheumatic heart disease.  
 
OBJECTIVES: 
The main objectives of this study is to determine the prevalence of clinical and 
subclinical rheumatic heart disease and to study the factors associated with both clinical 
and subclinical rheumatic heart disease in children presented to Hospital Universiti 
Sains Malaysia. 
 
METHODS: 
This study was conducted via retrospective record review of children with rheumatic 
heart disease who was referred or admitted to Hospital Universiti Sains Malaysia from 
2002 to 2014 who meet all the study criteria. 
 
RESULT 
There were 171 newly diagnosed rheumatic heart disease patients included in this study. 
The prevalence of clinical rheumatic heart disease and subclinical rheumatic heart 
disease were 86.5% and 13.5% respectively. The mean age at diagnosis of rheumatic 
heart disease was 10.8 years old and predominantly male with ratio of 1.1 to 1. The 
mean age for subclinical rheumatic heart disease was 9 years old and predominantly 
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female. All patients of rheumatic heart disease involved in this study were Malay. 
Majority of the patients of rheumatic heart disease were from rural areas and it 
accounted for 60.2%. Patient with rheumatic heart disease mainly have siblings more 
than 5 which is 52.6%, as compared to number of siblings less or equal to 5 which 
comprised only 47.4%. The low household income group showed high prevalence of 
rheumatic heart disease, in which 78.7% of the cases of clinical rheumatic heart disease 
and comprised of 56.3% cases of subclinical. The majority of the parents were educated 
up to secondary school level, which was comprised of 76.4%. Age was the only 
significant factor which influenced subclinical RHD compare to clinical RHD. 
 
CONCLUSION  
The prevalence of subclinical rheumatic heart disease in this study was comparable to 
other studies. Increasing age was less likely to develop subclinical rheumatic heart 
disease compare to clinical RHD. 
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CHAPTER 1: INTRODUCTION 
 
The prevalence and associated factors of clinical and subclinical rheumatic heart 
disease among rheumatic heart disease children in Kelantan. 
 
1.1   Overview Rheumatic Fever  
Rheumatic fever is an acute, non suppurative, immunologically mediated, 
multisystem inflammatory disease that occurs 10 days to 6 weeks after an episode of group 
A streptococcal pharyngitis (Kumar, 2010) in genetically susceptible hosts (Glenn G Fort, 
2011) commonly appears in children between the ages of 5 and 15, with only 20% of first-
time attacks occurring in adults (Kumar, 2007), and results from antibodies cross-reacting 
(Type II hypersensitivity) with tissues in the heart, joints, skin, and central nervous system 
at the level of B and T lymphocytes (Abul K. Abbas MBBS 2004). Acute rheumatic heart 
disease is a frequent manifestation during the active phase of RF and may progress over 
time to chronic rheumatic heart disease (RHD), of which most commonly mitral valve and 
less commonly aortic valve abnormalities are key manifestations (Kumar, 2010). 
Diagnosis of rheumatic fever or rheumatic heart disease are based on the set of 
guidelines known as Jones criteria (revised 1992). This criteria consist of clinical and 
laboratory findings and categories into major and minor criteria. The clinical features of 
major manifestation:   
1. carditis 
2.  polyarthritis  
3. sydenham chorea 
4.  erythema marginatum  
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5.  subcutaneous nodule.  
The minor manifestations consist:  
1. arthralgia 
2. fever 
3.  raised erythrocytes sedimentation rate or C- reactive protein  
4.  prolonged PR interval on electrocardiogram. 
  In order to make the diagnosis, two major or one major and two minor 
manifestations must be present, plus evidence of antecedent group A streptococcus 
infection. The evidence of antecedent group A streptococcus infection includes raised or 
rising streptococcal antibody titre, positive throat swab culture or rapid antigen test for 
group A streptococcus. Chorea and indolent carditis do not require evidence of antecedent 
group A streptococcus infection. For the recurrence episodes of rheumatic fever, the 
requirement only one major or several minor manifestations, plus evidence of antecedent 
group A streptococcus infection (WHO, 2004) (Refer table in appendix II). 
There are a number of hallmarks of acute carditis noted on physical examination of 
a patient with an initial episode of RF. There may be a prominent left ventricular (LV) 
impulse secondary to cardiac enlargement but not as localized as with chronic mitral 
regurgitation (MR). Because of recent onset, there is usually at most only mild LV dilation. 
Sinus tachycardia is common, but atrial fibrillation is rare. The first heart sound may vary 
from normal to diminished intensity, either because of MR, prolonged PR interval, or both. 
The second heart sound is normal or widely or variably split, depending on the degree of 
the MR. The pulmonary component of the second sound is accentuated with the presence of 
pulmonary hypertension caused by severe MR. Although classically the aortic second 
sound is diminished in chronic aortic insufficiency, in acute RF it is usually normal, even 
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with significant aortic regurgitation, because mobility of the aortic valve is not affected at 
the early phase. The soft, blowing, pansystolic murmur of MR is a hallmark of carditis in 
RF. The murmur is best heard at the apex and selectively conducted to the axilla and back; 
the latter suggests severe MR. A non-pansystolic murmur may occur when MR is mild, 
although it retains its high-frequency, soft, blowing character, which distinguishes it from 
the physiological murmurs seen in children. The apical diastolic murmur of Carey Coombs 
is often related to the severity of MR, but is also associated with flow disturbances caused 
by mitral valve deformity secondary to valvulitis, in addition to the increased flow in 
diastole. The murmur is typically mid-diastolic as opposed to the late diastolic accentuation 
seen with mitral stenosis. The aortic valve is involved in a minority of cases (up to 40 
percent) and is associated with an early diastolic murmur of aortic regurgitation best heard 
along the base and left sternal border. Aortic insufficiency in the absence of MR is 
uncommon. A murmur of functional tricuspid regurgitation may occur in the setting of 
severe heart failure, pulmonary hypertension, and right ventricular dilation, with associated 
neck vein distention and other hallmarks of tricuspid insufficiency. Traditionally, the 
diagnosis has been made on the basis of auscultation of mitral or, less commonly, aortic 
insufficiency in the setting of heart failure, with cardiomegaly in the most severe cases. 
Severe MR is most commonly associated with the worst prognosis—acute and sometimes 
refractory and fatal heart failure. This subgroup is most likely to develop significant 
chronic RHD, with an incidence as high as 90 percent. There is a linear relationship 
between the severity of MR during the first episode of RF and subsequent RHD (WHO, 
2004). 
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Because the valvulitis can be transient, repeated auscultation is appropriate. 
Whereas acute carditis may result in fulminant pulmonary oedema, in a significant 
percentage of patients the carditis is subclinical, setting the stage for scarring of the mitral 
or aortic valve apparatus with manifestations occurring years or decades later. Rheumatic 
tricuspid disease is uncommon, and pulmonic valve disease is rare. Although left 
ventricular dysfunction secondary to chronic valvulitis is thought to account for the 
majority of myocardial dysfunction seen, there is a characteristic regional wall motion 
abnormality seen in patients, primarily in the inferobasal segment of the heart adjacent to 
the mitral valve. The valvulitis typically involves the leaflets, but extends into the submitral 
apparatus in a significant percentage of cases. In the setting of LV dysfunction or 
pericarditis without valvular involvement, the consensus is that the pathology is unlikely to 
be secondary to RF. Because pericarditis alone is not diagnostic of rheumatic carditis, 
detection of an associated valvular lesion is important. Pericardial involvement is usually 
associated with significant valvulitis and may result in an effusion, but large effusions, 
chronic constriction, or tamponade are rare. Tachycardia and various arrhythmias are 
nonspecific findings. The use of endomyocardial biopsy for the diagnosis of rheumatic 
carditis has been explored but has not provided sufficient additional diagnostic information 
to warrant its use (WHO, 2004). 
 
1.2 History of Rheumatic Heart Disease 
Guillaume de Baillou (1538-1616), also known as Ballonius, first clearly 
distinguished acute arthritis from gout. Later on Thomas Sydenham (1624-1689) described 
chorea but failed to associate this entity with other manifestations of acute rheumatic fever 
(ARF). Raymond Vieussens (1641-1715) published pathologic descriptions of mitral 
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stenosis and aortic insufficiency. It remained, however, for William Charles Wells in 1812 
to emphasize the association of rheumatism and carditis and to provide the first clear 
description of subcutaneous nodules. Jean-Baptiste Bouillard in 1836 and Walter B. 
Cheadle in 1889 published extensive studies of rheumatic arthritis and carditis that have 
come to be regarded as classic works in this field, and form the basis for modern clinical 
concepts of ARF. In 1880, J. K. Fowler pointed out the association between sore throat and 
rheumatic fever. In 1904, Ludwig Aschoff described the specific rheumatic lesion in the 
myocardium (Gerald L. Mandell, 2010). 
 
1.3 Epidemiology 
Group A streptococcus has a global mortality range after human immunodeficiency 
virus (HIV), tuberculosis, and malaria. It was comparable to pathogens causing hepatitis, 
measles, and Haemophilus influenzae. Streptococcus pyogenes is responsible for a 
spectrum of diseases, ranging from pharyngitis to glomerulonephritis, necrotizing fasciitis 
and toxic shock syndrome. However, suppurative pharyngitis is the only well-established 
prequel to acute RF. It was estimated in 2005 that approximately 15.6 millions people had 
RF or RHD, with sub-Saharan Africa and South Central Asia accounting for the majority of 
cases (John E. Bennett MD 2010). 
There were estimated about 12 million individuals worldwide suffered from 
rheumatic fever and rheumatic heart disease in 1994, and at least 3 million required 
hospitalization for congestive heart failure (CHF). Majority of the patients with CHF 
required cardiac valve replacement surgery within 5–10 years. The mortality rate for RHD 
varied from 0.5 per 100 000 population in Denmark, to 8.2 per 100 000 population in 
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China. The estimated annual number of mortality from RHD for 2000 was 332,000 
worldwide (WHO, 2004). 
The prevalence of rheumatic heart disease up to 20 per cent of cardiology cases in 
Malaysia. The similar trend seen in other developing Asian countries. The reasons for this 
high prevalence in Malaysia are not immediately obvious but may be related to under 
treatment of streptococcal sore throats by medical practitioners. On the other hand, it may 
simply be due to the lack of patient awareness of the need to seek prompt medical attention 
for severe bacterial pharyngitis (Jamal F 1988). In Malaysia cardiovascular diseases rank 
number one cause of death since the beginning of the last decade. Among the 
cardiovascular diseases, coronary artery disease is the top killer. Systemic arterial 
hypertension comes next and valvular heart disease is the third killer of which rheumatic 
fever is the main cause. Of all new adult patients referred to the adult cardiac clinic in 
Hospital Universiti Sains Malaysia between 1991-1992, the commonest diagnosis made 
was rheumatic valvular heart disease (Ibrahim and Rahman, 1995). 
From 1920 to 1950, acute rheumatic fever (ARF) was the leading cause of death in 
U.S. children and the most common cause of heart disease in individuals younger than age 
40 years (John Marx, 2010). The incidence of ARF began to decline long before the 
introduction of antibiotics into clinical practice, decreasing from 250 to 100 
patients/100,000 population from 1862 to 1962 in Denmark. The introduction of antibiotics 
in 1950 rapidly accelerated this decline, until by 1980 the incidence ranged from 0.23 to 
1.88 patients/100,000, with disease occurring primarily in children and teenagers (Firestein 
et al., 2012). 
Only a few M serotypes (types 5, 14, 18, and 24) have been identified with 
outbreaks of ARF, suggesting that certain strains of group A streptococci may be more 
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“rheumatogenic” than others. In Trinidad, types 41 and 11 have been the most common 
strains isolated from the oropharynx of patients with ARF. Kaplan and colleagues isolated 
several M types from patients seen during an outbreak of ARF in Utah (Firestein et al., 
2012) However, some streptococcal strains capable of causing well-documented 
pharyngitis is generally capable of causing ARF (Gary S. Firestein, 2008). 
The incidence of acute rheumatic fever is closely related to streptococcal 
pharyngitis. The peak age of incidence is 5 to 15 years, but the primary case of rheumatic 
fever also can occur in adults. Acute rheumatic fever is rarely occur in children younger 
than 4 years old. This fact has led some author to speculate that development of the disease 
required repetition of streptococcal infections. There is no obvious gender predilection has 
been observed, but certain manifestations, such as Sydenham's chorea and mitral stenosis, 
are more prone to develop in female patients (Goldman and Schafer, 2011). 
Patients with a history of acute rheumatic fever and developed significant 
immunological response to streptococcal infection are susceptible to recurrent attacks of 
rheumatic fever. This is supported by the one long-term prospective study of patient with a 
history of rheumatic fever. The result showed that one of every five documented 
streptococcal infections gave rise to a recurrence of the disease. The risk of recurrence was 
more in patients with preexisting rheumatic heart disease and in those experiencing 
symptomatic throat infections, whereas the risk to develop recurrence attack were reduced 
with advancing age and with increasing interval since the most recent rheumatic attack 
(Goldman and Schafer, 2011). 
Rheumatic fever occurs in majority area in the worlds and it occur in all races 
without any racial predisposition. In temperate climates area, acute rheumatic fever peaks 
in the winter and early spring. The major environmental factors that influence occurrence of 
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rheumatic fever were overcrowding, as in large households and military barracks. 
Interpersonal spread of group A streptococci were more favorable in overcrowding area and 
perhaps enhances streptococcal virulence by increase frequent of human passage (Goldman 
and Schafer, 2011). 
Acute rheumatic fever is still common disease in developing countries such as the 
Middle East, the Indian, and Africa. The incidence of acute rheumatic fever is extremely 
high among indigenous populations such as the Maori of New Zealand and the Australian 
aborigines. This was contrasted to the incidence of acute rheumatic fever and the 
prevalence of rheumatic heart disease both in North America and in Western Europe during 
the 20th century where it showed the decline in number. Rates of fewer than 2 per 100,000 
school children were common, especially in affluent suburbs. The higher incidence rates 
reported in blacks peoples compare to whites appear to be due to socioeconomic factor 
rather than to genetic influence (Lee Goldman, 2008). 
 
1.4 Etiology and pathogenesis 
Even though there is little evidence for the direct involvement of group A 
streptococci in the affected tissues of ARF patients, there is a lot of epidemiologic and 
immunologic evidence indirectly implicating group A streptococci in the initiation of the 
disease process:  
(1) It is well known that outbreaks of ARF closely follow epidemics of either  
streptococcal sore throat or scarlet fever (Whitnack E. , 1980).  
(2) The incidence of subsequent ARF were markedly reduce after adequate 
treatment of documented streptococcal pharyngitis (Denny et al., 1950). 
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(3) Recurrence of disease in known patients with ARF were prevented by 
appropriate antimicrobial prophylaxis (Markowitz and Gerber, 1987).
(4) If one tests the sera of most ARF patients for three anti-streptococcal antibodies  
   
(streptolysin O, hyaluronidase, and streptokinase), most ARF patients (whether 
or not they recall an antecedent streptococcal sore throat) have elevated 
antibody titers to these antigens (Stollerman G H, 1956). 
Group A streptococci falls into two main classes based on differences in the C 
repeat regions of the M protein. One class is associated with streptococcal pharyngeal 
infection, and the other is commonly associated with impetigo. The particular strain of 
streptococci may be crucial in initiating the disease process. The pharyngeal site of 
infection with its large repository of lymphoid tissue also may be important in the initiation 
of the abnormal humoral response by the host to the antigens cross-reactive with target 
organs. Finally, although impetigo strains do colonize the pharynx, they do not seem to 
elicit as strong an immunologic response to the M protein moiety as do the pharyngeal 
strains. This may prove to be an important factor, especially in light of the known cross-
reactions between various streptococcal structures and mammalian proteins (Gary S. 
Firestein, 2008). 
The development of acute rheumatic fever requires antecedent infection with the 
group A streptococcus at the upper respiratory tract. While cutaneous streptococcal 
infection, a precursor of post-streptococcal acute glomerulonephritis, has never been shown 
to cause rheumatic fever (Lee Goldman, 2008). 
A study done by Ayoub and associates showed whites and black patient with 
rheumatic heart disease has an increase in frequency of HLA-DR4 and HLA-DR2 (Ayoub 
et al., 1986).  Other studies have implicated HLA-DR1 and HLA-DRW6 as susceptibility 
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factors in South African black patients with RHD (Maharaj et al., 1987). More recently, 
Guilherme and associates have reported an increased frequency of HLA-DR7 and HLA-
DW53 in RF patients in Brazil (Guilherme et al., 1991). 
  Shin da Lee speculate that the long-term decrease in GH and IGF-I and increase in 
MMP-9 activity may be partially involved in the long-term pathogenesis of heart failure in 
RHD patient and it will be use as possible diagnostic markers in RHD for developing heart 
failure (Lee et al., 2006).  
Recent studies found nanobacteria-like materials in the effected valves of rheumatic 
heart patients, which plays a center role in the calcifications of these valves and result in 
dysfunctional valves (Hu et al., 2010). 
 
1.5  Clinical Rheumatic Heart Disease   
Carditis is a single most important prognostic factor in rheumatic fever as valvulitis 
lead to permanent damage and the presence carditis in patient with rheumatic fever will 
determines the prophylactic strategy. The diagnosis of clinical rheumatic heart disease is 
based on the presence of significant cardiac murmur (suggestive of mitral and/ or aortic 
regurgitation), pericardial rub or an unexplained cardiomegaly with congestive heart 
failure. 
 
1.6 Subclinical Rheumatic Heart Disease 
Diagnosis of rheumatic heart disease or rheumatic carditis usually depends on 
detecting typical cardiac murmur (mitral murmurs and/ or aortic valvular regurgitation 
murmur). Two dimensional echo-doppler and colour flow Doppler echocardiography can 
detect silent, but significant mitral and aortic regurgitation in patient with acute rheumatic 
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fever. A new categories of rheumatic heart disease which is subclinical carditis or 
subclinical RHD has been proposed based on the presence of very mild silent but 
significant valvular regurgitation  in patient with chorea and polyarthritis (Folger and Hajar, 
1989).  
Subclinical RHD is defined as features of RHD on echocardiography in the absence 
of symptoms and signs of heart valve disease. Patient with subclinical valvular 
regurgitation may develop an audible murmur in two week (Abernethy et al., 1994), and 
may continue without audible murmur for 18 months to 5 year (Voss et al., 2001). 
Echocardiogram is known to be more sensitive than auscultation for detection of pathologic 
valve disease. It proved by data from the study conducted by Marijon and associates where 
the  comprehensive screening, including echocardiography in children might reveal a high 
prevalence of rheumatic heart disease (approximately 10 times) as compare to clinical 
screening (Marijon et al., 2007).  
A systemic review of studies on subclinical carditis also showed that approximately 
half of the patients diagnosed as subclinical RHD at time of ARF showed persistence or 
deterioration of their carditis in the following 2 year (Tubridy-Clark and Carapetis, 2007). 
 
1.7 Echocardiography 
Several studies have used echocardiography as a more sensitive tool than 
auscultation to detect valve pathology. Primarily mitral but occasional aortic insufficiency 
has been diagnosed in a minority of putative RF patients in whom characteristic murmurs 
were not heard, although this finding has not been uniform. Because echocardiographic-
Doppler findings in the absence of auscultatable murmurs are not specific for rheumatic 
valvulitis, the use of echocardiography alone to justify a diagnosis of carditis for this major 
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Jones criteria is a subject of controversy. Despite the development of criteria to differentiate 
pathological from functional regurgitation, including posterior direction of the mitral jet, 
holosystolic flow, significant turbulence in the MR jet, and MR seen in orthogonal planes, 
in general the inclusion of patients with “silent carditis” or “echocarditis” has been thought 
to result in overdiagnosis. MR in particular is seen in other febrile illnesses. Longitudinal 
studies of patients with carditis by echoardiography but not physical examination may shed 
light on the long-term implications of “silent carditis” (WHO, 2004). 
There is considerable inconsistency in the literature regarding the echocardiographic 
findings characteristic of acute rheumatic carditis. Mitral insufficiency is the most common 
finding, associated subsequently (but not acutely) with restricted leaflet motion rather than 
prolapse and with ventricular but not annular dilation. When chordal rupture occurs, 
however, both flail leaflets and prolapse are seen. Nodular lesions are seen in a significant 
minority (25 percent). Although it has been suggested that echocardiography may be 
helpful in settings such as concomitant pericarditis, in which auscultation may be difficult, 
MR is usually moderate or severe when pericarditis is secondary to RF and the murmur is 
detectable, despite a friction rub, which is frequently intermittent. Echocardiography is 
useful for confirming the findings on auscultation, excluding non-rheumatic causes (e.g., 
physiological murmurs or congenital heart disease), and sequential follow-up of valvular 
insufficiency, cardiac chamber size, pulmonary hypertension, valve thickening, and left 
ventricular systolic function (WHO, 2004). 
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1.8 WHO criteria to diagnose subclinical RHD with echocardiogram 
 Excluding the non-rheumatic causes, such as congenital mitral valve cleft and/or 
anomalies, degenerative floppy mitral valve, bicuspid aortic valve; and acquired 
valvular diseases due to infective endocarditis, systemic disease and others. 
 Silent, but significant, very mild (grade 0+) mitral and/or aortic valvular 
regurgitation. It is recommended that such significant mitral and/or aortic 
regurgitation be labelled as probable rheumatic heart disease (RHD) until proven 
otherwise (WHO, 2004). 
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1.8      Reasons for this study 
From the above discussion and literature review, these are the reasons for pursuing the 
study on prevalence and associated factors of clinical and subclinical rheumatic heart 
disease among RHD children in Kelantan. 
 This is the first study describing the subclinical RHD in Malaysia. 
 To determine the ratio of subclinical RHD in our population. 
 To determine the difference of the associated factors between subclinical and 
clinical RHD. 
 This study may help to determine whether it is worth to do wide echo screening on 
population. 
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CHAPTER  2 
 
STUDY OBJECTIVES AND HYPOTHESIS 
 
2.1 General Objectives 
 
To describe the characteristics of children with clinical and subclinical rheumatic heart 
disease (RHD) presented to HUSM  
 
2.2 Specific Objectives 
i). To determine the prevalence of clinical and subclinical case among rheumatic 
heart  
    disease children. 
 
ii) To compare the associated factors between clinical and subclinical cases in  
    rheumatic heart disease children. 
 
2.3      Study Hypothesis 
i) Significant number of subclinical cases among RHD who presented to HUSM 
            ii) Significant associated factor between clinical and subclinical cases in rheumatic     
    heart disease. 
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CHAPTER 3 
 
METHODOLOGY 
 
3.1 Study design and location 
This study was designed as a retrospective study. It was retrospectively reviewed 
hospital record of children with rheumatic heart disease who referred or admitted to 
Hospital Universiti Sains Malaysia (HUSM) from 2002 to 2014. HUSM is a tertiary centre 
that received referrals from other hospitals in Kelantan. HUSM was the only referral centre 
for paediatric cardiology in Kelantan until 2010. Since then, Hospital Raja Perempuan 
Zainab II started to have similar subspecialty facilities.  
 
3.2 Study population  
The reference population was the pediatric rheumatic heart disease patient in 
Kelantan whereas the source population was the newly diagnosed rheumatic heart disease 
who were referred as outpatient or admitted to Hospital Universiti Sains Malaysia, Kubang 
Kerian Kelantan. 
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3.3 Inclusion criteria 
All patient age from 3 year old to 18 year old at diagnosis and fulfilled Revised 
Jones Criteria 1992 with carditis at the time of diagnosis or incidental ECHO findings of 
rheumatic heart disease according to WHO echocardiography criteria ( please refer 
appendix II for Revised Jones Criteria). 
 
3.4 Exclusion criteria 
The exclusion criteria were those with missing or untraceable case notes and 
patients who were diagnosed as acute rheumatic fever without carditis. 
 
3.5 Ethical consideration 
The ethical clearance was obtained from Ethical Committee of  Pusat Pengajian 
Sains Perubatan (PPSP) Universiti Sains Malaysia (reference: 
USMKK/PPP/JEPeM[244.4(1.1). The medical records obtained remained confidential. No 
individual names were used and cases were coded accordingly.  
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3.6 Calculation of Sample Size and Sampling Method 
 
Objective 1: To determine the prevalence of clinical and subclinical case among RHD 
children in Kelantan.  
The sample size was calculated using single proportion sample size calculation. 
Population proportion formula. Anticipated population proportion (p) = 10% (0.1) (Eloi 
Marijon et al,  2007), Z score as 1.96 (for 95% confidence level), absolute precision at 5% 
(0.05).Therefore, the calculated sample size is 152. Considering dropout rate of 20%, the 
total sample required, N is: 
 
 N = 152 + 20% drop out 
        = 167 
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Objective 2:  
To compare the associated factors between clinical and subclinical cases in RHD children 
in Kelantan. 
The calculated sample size using PS software are as follow: 
(Arief Hermanu S, 2001) 
5 % precision and estimated power 80% 
Po = estimated exposed proportion    
        among control  
P1 = estimated exposed proportion among    
        cases 
 
The sample of calculation were as below: 
Male gender:  
Po = 0.45   P1 =  0.55 
Calculated sample size (n = 391) for each group 
Total sample size =782 + 78 (10 % drop out) = 860 
 
 
 
 
3.7 Duration of Study 
The study was conducted within two months (from March 2015 until May 2015). 
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3.8 Data Collection 
RHD cases were identified by obtaining the list of patient with the list of patient 
with the diagnosis of RHD (both outpatient and inpatient) during simple frame from the 
record office using their electronic database. The electronic database used is Coding Expert. 
This coding system followed the ICD-10 disease classification. For RHD, we had enter the 
code followed by the specified age group and sampling frame. 
The list of patient was than printed and submitted to record unit for folder tracing .After 
tracing the medical record for each patient, the detailed review was done to ascertain the 
RHD cases and ensure it had fulfilled the inclusion criteria. The duplication of patient was 
avoided by examination of name and date of birth for each patient. Each patient was given 
a code number.  
All relevant data were then entered anonymously using the serial number in the preset 
proforma. (Appendix B). Information extracted from the medical record for each patient 
included the following: 
• Demographic data: age, hospital registration number, telephone number, date of 
diagnosis, gender, race, address. 
• Type of RHD ( clinical or subclinical) 
• Associated factors studied: Age, gender, housing area, household income, number 
of sibling and parental education. 
• Clinical features ( Modified Jones Criteria 1992, major and minor criteria ) 
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• Echocardiography finding on diagnosis. 
• Outcome including asymptomatic, on antifailure and surgery (valve replacement 
surgery).  
• Type of prophylaxis ( oral penicillin or IM benzathine penicillin) 
 
 
 
3.9 Statistical Analysis 
Statistical analysis was done using IBM Statistical Packages for Social Science 
(SPSS) software version 22.0 licenced to Hospital Universiti Sains Malaysia. All data 
collection forms were given serial numbers. Data were entered, checked for data entry 
errors, explored and cleaned. The alpha (α) of 0.05 was taken as the level of significant at 
95% confidence interval. 
 Descriptive analyses were expressed as frequencies, means with standard deviation 
and percentages and presented as bar chart, pie chart, or line graphs as seen appropriate. 
Simple and multiple logistic regression analyses were used to identify the risk factors in 
this study which were significantly associated with subclinical rheumatic heart 
disease. Factors with a univariate p-value ≤ 0.25 were incorporated into a multivariate 
multiple logistic regression analysis using forward selection elimination.  Multivariate odds 
ratios for risk factor were calculated. A p-value ≤ 0.05 was considered as statistically 
significant for all statistical analyses in this study. 
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3.10 Operational definition 
Case definition of clinical and subclinical RHD 
• Clinical rheumatic heart disease: Patient fulfilled Jones criteria with evidence 
of carditis at the time of diagnosis. 
• Subclinical rheumatic heart disease: Patients who do not fulfilled the Jones 
Criteria but ECHO findings shows evidence of RHD based on WHO Echo 
criteria for RHD. 
 
Carditis:  
 Evidence of carditis consist of presence of cardiomegaly with congestive cardiac failure, 
pericarditis, tachycardia out of proportion of fever, pathological or changing murmur. 
 
Definition of positive result: 
• CRP > 30 mg/L 
• ASOT > 200unit/mL 
• ESR > 30mm/h 
• Positive throat swab culture :positive culture for group A streptococci 
• Prolonged PR interval: prolonged PR interval if PR interval is more than 200 ms in 
duration. 
Age: 
• All patient aged 3 year old until 18 year old who fulfilled the inclusion and 
exclusion criteria would be included in the study. 
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Type of housing area: 
• Definition of urban and rural area are based on definition by Jabatan Perangkaan 
Malaysia 2000 (Jabatan Perangkaan Malaysia, 2000) 
 
Household income: 
Definition of household income are according to the household income and basic amenities 
survey 2012 report, Jabatan Perangkaan Malaysia (Malaysia, 2012). 
• Low income define as household income less than RM 3,000 per month. 
• Middle income define as household income between than RM 3,000 to RM 5,000 
per month. 
• High income define as household income more than RM 5,000 per month. 
 
Parental education: 
• Parental education are categories as to primary (primary school), secondary 
(secondary school) and tertiary (college or university). 
 
Echocardiogram: 
• Echocardiogram finding at first diagnosis will be recorded. All echocardiogram 
were performed by cardiologist or echocardiographer at the cardiology unit, 
Hospital Universiti Sains Malaysia. 
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Echocardiography criteria for diagnosis for subclinical RHD  
• Excluding the non -rheumatic causes, such as congenital mitral valve cleft and/or 
anomalies, degenerative floppy mitral valve, bicuspid aortic valve, and acquired 
valvular disease due to infective endocarditis, systemic disease and other. 
• Criteria used to define subclinical RHD Based on Doppler characteristic of the 
valvular regurgitation and morphological criteria. 
• Doppler criteria (WHO criteria) to diagnosed subclinical RHD; define by the 
association of the regurgitation jet > 1 cm in length, seen in at least 2 planes, a 
mosaic colour jet with a peak velocity > 2.5 m/s, persisting throughout systole and 
diastole. 
• Morphological criteria :  
1) Leaflet morphology(typical marked thickening of the margin) 
2) Leaflet mobility (abnormal motion due to the posterior leaflet tip restriction) 
3) Subvalvular apparatus morphology (prominent thickening most often just below 
the valve, and shortening of chordal structures)  
• Echo grading of valvular regurgitation: 
0: Nil, including physiological or trivial regurgitant jet <1.0 cm, narrow, small, of 
short duration, early systolic at mitral valve or early diastolic at aortic valve. 
0+: Very mild regurgitant jet, more than 1.0 cm, wider, localized immediately 
above or below the valve, throughout systole at the mitral valve or diastole at the 
aortic valve (clinically, no murmur audible). 
1+: Mild regurgitant jet. 
2+: Moderate regurgitant jet, longer and at a wider area. 
